Merck KGaA in late-stage talks to acquire SpringWorks for USD 3.5 billion Ruchika Sharma27 April 2025 4:00 PM ISTBengaluru: Merck KGaA, a science and technology company, is in late-stage negotiations to buy SpringWorks Therapeutics, a US based...
Bayer arm AskBio elects Independent Director Dr Laura Sepp Lorenzino to Board Ruchika Sharma9 April 2025 11:30 AM ISTResearch Triangle Park: AskBio Inc., a gene therapy company wholly owned and independently operated subsidiary of Bayer AG, has announced...
Merck Capvaxive gets European Commission nod for prevention of Invasive Pneumococcal Disease, Pneumococcal Pneumonia in adults Ruchika Sharma27 March 2025 12:15 PM ISTEuropean Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and...
Merck gets rights to develop, commercialize Jiangsu Hengrui Pharma heart drug worldwide, excluding Greater China region Ruchika Sharma25 March 2025 5:22 PM ISTThe transaction is expected to close in the second quarter of 2025.
Merck injected version of Keytruda faces possible patent challenge: Report Ruchika Sharma6 March 2025 5:06 PM ISTMerck's newly developed injected version of its blockbuster cancer drug, Keytruda, may be at the center of a potential patent dispute,...
Merck to increase workforce at Indian sites by year end Ruchika Sharma1 March 2025 3:54 PM ISTDrug Maker Merck expects to boost employment in India with increment in its workforce across its India sites by the end of the year, a senior...
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma Ruchika Sharma27 Feb 2025 3:17 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Merck Welireg receives European Commission nod for two indications Ruchika Sharma19 Feb 2025 10:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has received conditional approval from the European Commission (EC) for...
Merck eyes SpringWorks Therapeutics in potential pharma deal Ruchika Sharma12 Feb 2025 12:30 PM ISTNew York: Merck KGaA, the German healthcare and technology conglomerate, has announced that it is in advanced negotiations to acquire SpringWorks...
Merck begins trial evaluating Zilovertamab Vedotin for previously untreated Diffuse Large B-Cell Lymphoma Ruchika Sharma9 Feb 2025 10:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of waveLINE-010, a pivotal Phase 3 clinical trial...
Merck gets positive EU CHMP opinion for Pneumococcal vaccination in adults Ruchika Sharma2 Feb 2025 2:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the Committee for Medicinal Products for Human Use (CHMP)...
Merck to stop trial evaluating Winrevair early in pulmonary arterial hypertension Ruchika Sharma31 Jan 2025 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the Phase 3 HYPERION study evaluating WINREVAIR...
